Avita Medical Inc.

RCEL Healthcare Medical Devices

Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 17.8%, EPS grew 33.8%, free cash flow grew 66.5% and total debt rose 10.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

13.04 0.37 −2.76%
Market cap
$333.1M
P/E
0.0×
Fwd P/E
−3.6×
Dividend yield
—
F-score
3/9
Altman Z
−11.96
Beneish M
−4.09
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 3 3 3
ROE
(1,746.27%) 799.72% 326.92% 211.55%
ROA
(67.07%) (71.40%) (74.88%) (81.36%)
ROIC
(211.01%) (334.18%) (288.05%) (306.20%)
Return on Tangible Assets
458.93% 261.83% 169.09% 131.98%
Average Days of Receivables
45.44 46.31 49.87 47.62
Free Cash Flow per Share
(26.15) (23.57) (21.22) (16.42)
Free Cash Flow
(37.13) (32.83) (32.40) (25.25)
Capital Expenditures
(3.29) (1.64) (1.44) (1.02)
Other line items
Cash ROIC
(62.83%) (73.76%) (87.01%) (84.28%)
Accounts Receivable Turnover
7.46 6.86 6.60 7.13
Accounts Payable Turnover
1.91 1.68 1.70 2.04
Inventory Turnover
1.75 1.80 1.86 2.18
Average Days of Payables
251.43 255.59 195.44 168.06
Days of Inventory on Hand
224.54 197.59 165.58 138.33
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
27.62% 29.10% 27.90% 26.64%
Selling, General and Administrative Expense of Revenue
114.25% 112.43% 108.07% 101.48%
Share Based Compensation of Revenue
15.12% 13.29% 10.96% 9.57%
Interest Coverage
(6.78) (8.71) (7.73) (6.97)
Operating CF/Net income
0.70 0.64 0.68 0.56
Depreciation/Fixed assets
0.21 0.27 0.30 0.33
Capex/Depreciation
(1.60) (0.70) (0.59) (0.41)
Revenue per Share
51.00 51.41 47.38 49.19
Operating CF per Share
(23.83) (22.39) (20.27) (15.76)
Capex per Share
(2.32) (1.18) (0.94) (0.66)
Capex to Sales
0.05 0.02 0.02 0.01

Fold the line items

Columns are period end dates